Lung abscess as a complication of Lemierre Syndrome in adolescents: a single center case reports and review of the literature.
Adolescents
Case report
EVALD
Fusobacterium necrophorum
Lemierre syndrome
Lung abscess
Journal
Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759
Informations de publication
Date de publication:
10 Aug 2023
10 Aug 2023
Historique:
received:
13
05
2023
accepted:
20
07
2023
medline:
14
8
2023
pubmed:
11
8
2023
entrez:
10
8
2023
Statut:
epublish
Résumé
Fusobacterium necrophorum is an anaerobic, gram-negative, non-motile, filamentous, non-spore forming bacillus found in the oral cavity, gastrointestinal tract, and female genital tract, responsible of a rare disease named Lemierre Syndrome, characterized by septic thrombophlebitis of the internal jugular vein, which mainly affects previously healthy adolescents and young adults; some risk factors are reported, as smoking or primary viral or bacterial infection leading to the disruption of mucosa. The syndrome originates commonly from an upper respiratory infection such as pharyngotonsillitis, acute otitis media, cervical lymphadenitis, sinusitis, or odontogenic abscess, and may result in multiorgan metastasis, more frequently leading to pulmonary complications, especially lung abscesses. We describe two cases of adolescents with atypical Lemierre Syndrome evaluated in a tertiary care center, one with a confirmed infection by Fusobacterium necrophorum and one with a presumptive diagnosis based on clinical features, who developed lung abscesses needing a prolonged antibiotic course and hospitalization. Of interest, both were user of electronic cigarette, configuring a possible new risk factor. The proper diagnosis of Lemierre Syndrome is often difficult to establish, so a high degree of suspicion is needed, especially in the case of lung abscesses in otherwise healthy adolescents. The current study will contribute to providing insight into Lemierre Syndrome clinical presentation and management in adolescents, promoting awareness for a rare but potentially fatal disease. Moreover, it suggests a possible relationship between Lemierre syndrome and the use of electronic cigarette, that should be investigated by future studies.
Sections du résumé
BACKGROUND
BACKGROUND
Fusobacterium necrophorum is an anaerobic, gram-negative, non-motile, filamentous, non-spore forming bacillus found in the oral cavity, gastrointestinal tract, and female genital tract, responsible of a rare disease named Lemierre Syndrome, characterized by septic thrombophlebitis of the internal jugular vein, which mainly affects previously healthy adolescents and young adults; some risk factors are reported, as smoking or primary viral or bacterial infection leading to the disruption of mucosa. The syndrome originates commonly from an upper respiratory infection such as pharyngotonsillitis, acute otitis media, cervical lymphadenitis, sinusitis, or odontogenic abscess, and may result in multiorgan metastasis, more frequently leading to pulmonary complications, especially lung abscesses.
CASE PRESENTATION
METHODS
We describe two cases of adolescents with atypical Lemierre Syndrome evaluated in a tertiary care center, one with a confirmed infection by Fusobacterium necrophorum and one with a presumptive diagnosis based on clinical features, who developed lung abscesses needing a prolonged antibiotic course and hospitalization. Of interest, both were user of electronic cigarette, configuring a possible new risk factor. The proper diagnosis of Lemierre Syndrome is often difficult to establish, so a high degree of suspicion is needed, especially in the case of lung abscesses in otherwise healthy adolescents.
CONCLUSION
CONCLUSIONS
The current study will contribute to providing insight into Lemierre Syndrome clinical presentation and management in adolescents, promoting awareness for a rare but potentially fatal disease. Moreover, it suggests a possible relationship between Lemierre syndrome and the use of electronic cigarette, that should be investigated by future studies.
Identifiants
pubmed: 37563612
doi: 10.1186/s13052-023-01499-4
pii: 10.1186/s13052-023-01499-4
pmc: PMC10413500
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Review
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
96Informations de copyright
© 2023. Società Italiana di Pediatria.
Références
Radiol Case Rep. 2018 Mar 30;13(3):618-621
pubmed: 30042808
Lancet Infect Dis. 2007 Mar;7(3):233
pubmed: 17317605
Acta Clin Belg. 2019 Jun;74(3):206-210
pubmed: 29783881
JAMA. 2022 Jan 11;327(2):129-137
pubmed: 35015038
Pediatrics. 2020 Apr;145(4):
pubmed: 32132153
Medicine (Baltimore). 1989 Mar;68(2):85-94
pubmed: 2646510
Postgrad Med J. 1999 Mar;75(881):141-4
pubmed: 10448489
Eur J Clin Microbiol Infect Dis. 2008 Sep;27(9):779-89
pubmed: 18330604
Br J Nurs. 2013 Oct 10-23;22(18):1075-8
pubmed: 24121852
Hamostaseologie. 2019 Feb;39(1):76-86
pubmed: 30071559
Int J Pediatr Otorhinolaryngol. 2015 Jul;79(7):953-8
pubmed: 25980688
Klin Padiatr. 2010 Dec;222(7):464-6
pubmed: 20862633
ORL J Otorhinolaryngol Relat Spec. 2019;81(4):234-239
pubmed: 31315119
Pediatr Hematol Oncol. 2020 May;37(4):344-352
pubmed: 32138584
J Microbiol Immunol Infect. 2020 Aug;53(4):513-517
pubmed: 32303484
Pediatr Gastroenterol Hepatol Nutr. 2018 Jul;21(3):214-217
pubmed: 29992123
Ann Transl Med. 2015 Aug;3(13):183
pubmed: 26366400
Anaerobe. 2005 Dec;11(6):308-11
pubmed: 16701590
Pediatr Radiol. 2003 Apr;33(4):281-3
pubmed: 12709764
Medicine (Baltimore). 2002 Nov;81(6):458-65
pubmed: 12441902
J Infect. 2017 Jun;74 Suppl 1:S47-S53
pubmed: 28646962
Eur J Clin Microbiol Infect Dis. 1992 Nov;11(11):1016-20
pubmed: 1295754
Radiographics. 2018 Jul-Aug;38(4):1239-1263
pubmed: 29995618
Pediatrics. 2005 Oct;116(4):e543-8
pubmed: 16147971
Pediatr Infect Dis J. 1988 Jun;7(6):410-4
pubmed: 3293000
J Emerg Med. 2013 Feb;44(2):e177-82
pubmed: 22989693
Infect Drug Resist. 2016 Sep 14;9:221-227
pubmed: 27695351
Int Arch Otorhinolaryngol. 2020 Jul;24(3):e379-e385
pubmed: 32754251
Anaerobe. 2016 Dec;42:89-97
pubmed: 27693542
Eur J Pediatr. 2002 Nov;161(11):616-8
pubmed: 12424589
Pediatr Infect Dis J. 2020 Dec;39(12):e445-e447
pubmed: 33003102
Pediatr Infect Dis J. 2003 Oct;22(10):921-3
pubmed: 14551494
Arch Intern Med. 1987 Sep;147(9):1581-3
pubmed: 3632166
Crit Care Med. 2002 Jul;30(7):1644-7
pubmed: 12130992
Int J Infect Dis. 2020 May;94:110-115
pubmed: 32126323
Int J Pediatr Otorhinolaryngol. 2020 Sep;136:110213
pubmed: 32797805
Pediatr Infect Dis J. 2013 Nov;32(11):1301-2
pubmed: 24141806
Lancet. 2020 Sep 12;396(10253):786-798
pubmed: 32919518
Clin Microbiol Rev. 2007 Oct;20(4):622-59
pubmed: 17934077
J Intern Med. 2021 Mar;289(3):325-339
pubmed: 32445216
CJEM. 2004 Jul;6(4):285-7
pubmed: 17382008
Front Pediatr. 2021 Oct 04;9:698613
pubmed: 34737999
Am Rev Respir Dis. 1984 Sep;130(3):510-3
pubmed: 6383158
Pediatr Infect Dis J. 2018 Sep;37(9):e246-e248
pubmed: 29389826
Chest. 2012 Feb;141(2 Suppl):e737S-e801S
pubmed: 22315277
Curr Infect Dis Rep. 2000 Apr;2(2):168-173
pubmed: 11095853
Am J Otolaryngol. 2010 Jan-Feb;31(1):38-45
pubmed: 19944898
J Med Microbiol. 2002 Mar;51(3):269-272
pubmed: 11871622
Lancet Infect Dis. 2012 Oct;12(10):808-15
pubmed: 22633566
J Radiol Case Rep. 2022 Mar 1;16(3):1-14
pubmed: 35529424
Pediatr Emerg Care. 2007 Feb;23(2):103-5
pubmed: 17351409
J Pediatr Hematol Oncol. 2017 Aug;39(6):e325-e327
pubmed: 28085751
J Am Board Fam Pract. 1995 Sep-Oct;8(5):384-91
pubmed: 7484226